Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[TG Therapeutics, Inc.](/topic/$tgtx)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$tgtx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$tgtx/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XXX% +67%  
**1 Month**: XX% +6%  
**6 Months**: XX% -X%  
**1 Year**: XX% -X%  
**1-Year High**: XX% on 2025-07-08  
**1-Year Low**: XX% on 2025-02-16  

**Most Supportive Themes**
- **Positive Data for Briumvi:** (35%) Enthusiasm for Briumvi's performance in treating relapsing multiple sclerosis.
- **Azer-cel Car-T Therapy:** (25%) Excitement surrounding the first patient treated with Azer-cel, an allogeneic Car-T therapy drug.
- **Analyst Price Targets:** (15%) Mentions of analyst price targets and positive outlooks for TGTX.
  
**Most Critical Themes**
- **General Market Sentiment:** (10%)  Some posts mention the stock is not moving up despite higher profits, and some are critical of the stock's performance.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXX      | XX% | XXX     | XX% | XX       | X% |
| Reddit  | XX       | X%  | X       | X%  | X        | X% |
| TikTok  | X        | X%  | X       | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXX      | XX% | XXX     | XX% | XX       | X% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

TG Therapeutics, Inc.

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% +67%
1 Month: XX% +6%
6 Months: XX% -X%
1 Year: XX% -X%
1-Year High: XX% on 2025-07-08
1-Year Low: XX% on 2025-02-16

Most Supportive Themes

  • Positive Data for Briumvi: (35%) Enthusiasm for Briumvi's performance in treating relapsing multiple sclerosis.
  • Azer-cel Car-T Therapy: (25%) Excitement surrounding the first patient treated with Azer-cel, an allogeneic Car-T therapy drug.
  • Analyst Price Targets: (15%) Mentions of analyst price targets and positive outlooks for TGTX.

Most Critical Themes

  • General Market Sentiment: (10%) Some posts mention the stock is not moving up despite higher profits, and some are critical of the stock's performance.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXX XX% XXX XX% XX X%
Reddit XX X% X X% X X%
TikTok X X% X X% X X%
Total XXX XX% XXX XX% XX X%
TG Therapeutics, Inc. (TGTX) Sentiment
/topic/$tgtx/sentiment